F78.A1 SYNGAP1-related intellectual disability

Name of the Condition

• Common Name: SYNGAP1-related Intellectual Disability
• Technical/Medical Term: SYNGAP1-related Intellectual Disability

Summary

SYNGAP1-related intellectual disability is a neurodevelopmental disorder characterized by significant limitations in intellectual functioning and adaptive behavior, which manifest during the developmental period. These limitations affect conceptual, social, and practical adaptive skills. The condition is caused by pathogenic variants in the SYNGAP1 gene and is distinct from other genetic or non-genetic intellectual disabilities.

Causes

The condition is caused by pathogenic variants (mutations) in the SYNGAP1 gene, which plays a critical role in synaptic function and neuronal development. These genetic changes disrupt normal brain development and function, leading to the observed intellectual and behavioral features. Inheritance is typically autosomal dominant, though de novo mutations (new mutations not inherited from parents) are common.

Risk Factors

• Family history of SYNGAP1-related disorders
• De novo genetic mutations (spontaneous occurrence)
• Parental germline mosaicism (rare, where parents carry the mutation in some cells but not others)

Symptoms

• Significant limitations in intellectual functioning
• Developmental delay, particularly in speech and motor skills
• Epilepsy or seizure disorders
• Behavioral issues (e.g., autism spectrum features, attention deficits)
• Hypotonia (low muscle tone) in infancy

Diagnosis

Diagnosis involves a combination of clinical evaluation, developmental assessment, and genetic testing. Clinical features suggestive of SYNGAP1-related intellectual disability, such as developmental delay and epilepsy, prompt consideration for genetic testing. Confirmatory testing typically includes sequencing of the SYNGAP1 gene, which may identify pathogenic variants. Exclusion of other genetic or non-genetic causes of intellectual disability is also part of the diagnostic process.

Treatment Options

Management is supportive and multidisciplinary, focusing on addressing specific symptoms and improving quality of life. Interventions may include:

• Early intervention services (e.g., speech, occupational, and physical therapy)
• Antiepileptic medications for seizure control
• Behavioral therapies for autism spectrum or attention-related symptoms
• Educational support tailored to individual needs

Prognosis and Follow-Up

Prognosis varies depending on the severity of symptoms and associated conditions (e.g., epilepsy). Most individuals require lifelong support for intellectual and adaptive functioning. Regular follow-up with neurologists, geneticists, and developmental specialists is recommended to monitor symptoms, adjust treatments, and address emerging needs.

Complications

• Severe epilepsy that may be refractory to treatment
• Worsening of behavioral or psychiatric symptoms over time
• Increased risk of secondary health issues due to mobility or communication challenges

Lifestyle & Prevention

While the genetic cause cannot be prevented, early intervention and supportive care can improve outcomes. Families may benefit from genetic counseling to understand recurrence risks and options for future pregnancies.

When to Seek Professional Help

Seek medical evaluation if a child shows signs of developmental delay, seizures, or behavioral abnormalities. Early diagnosis allows for timely intervention and support.

Tips for Medical Coders

Document the presence of SYNGAP1-related intellectual disability with the specific code F78.A1. Ensure clinical documentation supports the diagnosis, including genetic confirmation (if available) and associated features (e.g., epilepsy, developmental delays). Note that this code is specific to SYNGAP1-related etiology and should not be used for other genetic or non-genetic intellectual disabilities.